Annual Total Long Term Liabilities
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, FRTX annual total long term liabilities is $0.00, unchanged on December 31, 2023.
- During the last 3 years, FRTX annual total long term liabilities has fallen by -$146.00 thousand (-100.00%).
- FRTX annual total long term liabilities is now -100.00% below its all-time high of $8.66 million, reached on December 1, 2003.
Performance
FRTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, FRTX quarterly total long term liabilities is $0.00, unchanged on December 31, 2023.
- Over the past year, FRTX quarterly long term liabilities has stayed the same.
- FRTX quarterly long term liabilities is now -100.00% below its all-time high of $9.67 million, reached on March 1, 2004.
Performance
FRTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
FRTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | -100.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
FRTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Fresh Tracks Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | - |
| Dec 2021 | - | $0.00(-100.0%) |
| Sep 2021 | - | $18.00 K(-50.0%) |
| Jun 2021 | - | $36.00 K(-89.0%) |
| Mar 2021 | - | $326.00 K(+123.3%) |
| Dec 2020 | $146.00 K(+100.0%) | $146.00 K(-17.5%) |
| Sep 2020 | - | $177.00 K(-35.4%) |
| Jun 2020 | - | $274.00 K(+417.0%) |
| Mar 2020 | - | $53.00 K(-27.4%) |
| Dec 2019 | $73.00 K(>+9900.0%) | $73.00 K(-98.7%) |
| Sep 2019 | - | $5.84 M(>+9900.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(-100.0%) |
| Jun 2016 | - | $90.00 K(-60.0%) |
| Mar 2016 | - | $225.00 K(-37.3%) |
| Dec 2015 | $359.00 K(-58.1%) | $359.00 K(-27.3%) |
| Sep 2015 | - | $494.00 K(-20.1%) |
| Jun 2015 | - | $618.00 K(-16.1%) |
| Mar 2015 | - | $737.00 K(-13.9%) |
| Dec 2014 | $856.00 K(-33.5%) | $856.00 K(-12.1%) |
| Sep 2014 | - | $974.00 K(-10.0%) |
| Jun 2014 | - | $1.08 M(-8.7%) |
| Mar 2014 | - | $1.19 M(-8.0%) |
| Dec 2013 | $1.29 M(-22.3%) | $1.29 M(-7.4%) |
| Sep 2013 | - | $1.39 M(-6.2%) |
| Jun 2013 | - | $1.48 M(-5.5%) |
| Mar 2013 | - | $1.57 M(-5.3%) |
| Dec 2012 | $1.66 M(-15.6%) | $1.66 M(-4.9%) |
| Sep 2012 | - | $1.74 M(-4.2%) |
| Jun 2012 | - | $1.82 M(-3.8%) |
| Mar 2012 | - | $1.89 M(-3.7%) |
| Dec 2011 | $1.96 M(-11.2%) | $1.96 M(-3.5%) |
| Sep 2011 | - | $2.04 M(-2.9%) |
| Jun 2011 | - | $2.10 M(-2.6%) |
| Mar 2011 | - | $2.15 M(-2.6%) |
| Dec 2010 | $2.21 M(-7.1%) | $2.21 M(-2.5%) |
| Sep 2010 | - | $2.27 M(-1.8%) |
| Jun 2010 | - | $2.31 M(-1.5%) |
| Mar 2010 | - | $2.35 M(-1.5%) |
| Dec 2009 | $2.38 M(-3.6%) | $2.38 M(-1.7%) |
| Sep 2009 | - | $2.42 M(-0.9%) |
| Jun 2009 | - | $2.44 M(-0.6%) |
| Mar 2009 | - | $2.46 M(-0.6%) |
| Dec 2008 | $2.47 M | $2.47 M(-0.4%) |
| Sep 2008 | - | $2.48 M(-0.6%) |
| Jun 2008 | - | $2.49 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $2.51 M(-2.0%) |
| Dec 2007 | $2.56 M(-13.7%) | $2.56 M(-3.2%) |
| Sep 2007 | - | $2.65 M(-3.1%) |
| Jun 2007 | - | $2.73 M(-3.4%) |
| Mar 2007 | - | $2.83 M(-4.8%) |
| Dec 2006 | $2.97 M(-45.4%) | $2.97 M(-13.3%) |
| Sep 2006 | - | $3.43 M(-16.0%) |
| Jun 2006 | - | $4.08 M(-14.7%) |
| Mar 2006 | - | $4.79 M(-12.1%) |
| Dec 2005 | $5.44 M(-33.7%) | $5.44 M(-6.7%) |
| Sep 2005 | - | $5.83 M(-14.5%) |
| Jun 2005 | - | $6.82 M(-10.6%) |
| Mar 2005 | - | $7.63 M(-7.0%) |
| Dec 2004 | $8.21 M(-5.2%) | $8.21 M(+2.1%) |
| Sep 2004 | - | $8.04 M(-12.1%) |
| Jun 2004 | - | $9.15 M(-5.4%) |
| Mar 2004 | - | $9.67 M(+11.7%) |
| Dec 2003 | $8.66 M(+100.5%) | $8.66 M(-8.8%) |
| Sep 2003 | - | $9.50 M(+16.6%) |
| Jun 2003 | - | $8.14 M(+111.2%) |
| Mar 2003 | - | $3.86 M(-10.8%) |
| Dec 2002 | $4.32 M(-5.0%) | $4.32 M(+18.0%) |
| Sep 2002 | - | $3.66 M(-11.7%) |
| Jun 2002 | - | $4.15 M(+6.6%) |
| Mar 2002 | - | $3.89 M(-14.4%) |
| Dec 2001 | $4.55 M(-11.2%) | $4.55 M(-11.7%) |
| Sep 2001 | - | $5.15 M(-5.2%) |
| Jun 2001 | - | $5.43 M(-2.5%) |
| Mar 2001 | - | $5.57 M(+8.8%) |
| Dec 2000 | $5.12 M(+631.6%) | $5.12 M(-0.7%) |
| Sep 2000 | - | $5.16 M(-4.0%) |
| Jun 2000 | - | $5.37 M(+3.7%) |
| Mar 2000 | - | $5.18 M(+640.0%) |
| Dec 1999 | $700.00 K(-12.5%) | $700.00 K(0.0%) |
| Sep 1999 | - | $700.00 K(-12.5%) |
| Jun 1999 | - | $800.00 K(+14.3%) |
| Mar 1999 | - | $700.00 K(-12.5%) |
| Dec 1998 | $800.00 K(-33.3%) | $800.00 K(-11.1%) |
| Sep 1998 | - | $900.00 K(-10.0%) |
| Jun 1998 | - | $1.00 M(-9.1%) |
| Mar 1998 | - | $1.10 M(-8.3%) |
| Dec 1997 | $1.20 M(-20.0%) | $1.20 M(0.0%) |
| Sep 1997 | - | $1.20 M(-7.7%) |
| Jun 1997 | - | $1.30 M(-18.8%) |
| Mar 1997 | - | $1.60 M(+6.7%) |
| Dec 1996 | $1.50 M(+400.0%) | $1.50 M(+7.1%) |
| Sep 1996 | - | $1.40 M(+55.6%) |
| Jun 1996 | - | $900.00 K(+200.0%) |
| Mar 1996 | - | $300.00 K(0.0%) |
| Dec 1995 | $300.00 K(-40.0%) | $300.00 K(-25.0%) |
| Sep 1995 | - | $400.00 K(0.0%) |
| Jun 1995 | - | $400.00 K(-20.0%) |
| Mar 1995 | - | $500.00 K(0.0%) |
| Dec 1994 | $500.00 K(0.0%) | $500.00 K(0.0%) |
| Sep 1994 | - | $500.00 K(0.0%) |
| Jun 1994 | - | $500.00 K(0.0%) |
| Mar 1994 | - | $500.00 K(0.0%) |
| Dec 1993 | $500.00 K(+66.7%) | $500.00 K(+25.0%) |
| Sep 1993 | - | $400.00 K(+33.3%) |
| Jun 1993 | - | $300.00 K(0.0%) |
| Mar 1993 | - | $300.00 K(0.0%) |
| Dec 1992 | $300.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1991 | $300.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1990 | $300.00 K | $300.00 K |
FAQ
- What is Fresh Tracks Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual total long term liabilities year-on-year change?
- What is Fresh Tracks Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly long term liabilities year-on-year change?
What is Fresh Tracks Therapeutics annual total long term liabilities?
The current annual total long term liabilities of FRTX is $0.00
What is the all time high annual total long term liabilities for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual total long term liabilities is $8.66 M
What is Fresh Tracks Therapeutics annual total long term liabilities year-on-year change?
Over the past year, FRTX annual total long term liabilities has changed by $0.00 (0.00%)
What is Fresh Tracks Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of FRTX is $0.00
What is the all time high quarterly long term liabilities for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly total long term liabilities is $9.67 M
What is Fresh Tracks Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, FRTX quarterly total long term liabilities has changed by $0.00 (0.00%)